Poll: Which Areas of PV you are Most Likely to Automate?
- End-to-end to case processing 39% 39%
- Case intake 24% 24%
- Duplicate check 20% 20%
- Narrative generation 11% 11%
- Quality check 4% 4%
- Follow-up processing 2% 2%
ArisGlobal has recently launched LifeSphere MultiVigilance 10 (LSMV10), a next-generation drug safety system with production-ready automation that has been tried and tested by major Life Sciences companies and a leading global authority. In fact, LSMV10 is the chosen safety system of the US Food and Drug Administration (FDA), thanks to its production-ready automation. LSMV10’s automation capabilities have been implemented by early adopters who have embraced the solution to automate data extraction, duplicate checks, validation, triage, and coding. The system can make intelligent assessment of cases and determine the validity.
LSMV10 is also enabled with advanced Natural Language Processing (NLP) to process unstructured data, complete automated follow-up management and automate language translations. The system allows for touchless case processing, with minimal human intervention, or a hybrid combination if one would want human intervention at certain points.
To learn about FDA adopting PV automation through LifeSphere MultiVigilance click here.
In our next blog, we will discuss a real case study of automation implementation and how PV processes are streamlined with LifeSphere MultiVigilance.If you are curious, view the on-demand webinar for complete insights and discussion, here
(This is Blog #2 in a series of 3 from Automation in Pharmacovigilance: From Hype to Reality webinar.)